Mr Francois Laliberte
Analysis Group, Montreal (Canada)
Hospitalizations and other healthcare resource utilization among patients with deep vein thrombosis treated with rivaroxaban versus low-molecular-weight heparin and warfarin in the outpatient setting
Event: ESC Congress 2016
Topic: Thrombosis and coagulation
Session: Thrombosis and coagulation
ESC 365 is supported by
